The forecast for the tuberculosis treatment success rate for previously treated cases in China shows a slight decline from 77% in 2024 to 75% in 2028. In 2023, the success rate for the same demographic stood close to the 77% mark. The data indicates stability from 2024 to 2025 with no change, followed by a decrease in subsequent years, with a year-on-year decline of approximately 1% in 2026 and again in 2027. The five-year compound annual growth rate (CAGR) suggests a marginal yearly decrease, trending slightly downward over the period.
Future trends to watch for include:
- Potential introduction of new treatments or intervention strategies that could reverse the declining trend.
- The impact of governmental public health initiatives focused on improving treatment adherence and health outcomes.
- Emerging challenges or changes in the socioeconomic landscape that could influence health care access and treatment success.
